Showing 11,701 - 11,720 results of 24,831 for search '(( 50 ((ms decrease) OR (mean decrease)) ) OR ( 100 ((a decrease) OR (we decrease)) ))', query time: 0.94s Refine Results
  1. 11701

    Table 6_Soybean yield, nutrient use efficiency, and economic returns of phosphorus and potassium in Ghana’s interior savanna.docx by George A. Awuni (14632778)

    Published 2024
    “…</p>Materials and methods<p>The treatments were 4 × 4 factorial combinations of P at 0, 25, 50, and 100 P<sub>2</sub>O<sub>5</sub> (kg ha<sup>−1</sup>) and K at 0, 25, 50, and 100 K<sub>2</sub>O (kg ha<sup>−1</sup>), and their combinations laid out in a randomized complete block design with four replications. …”
  2. 11702

    Image 1_Soybean yield, nutrient use efficiency, and economic returns of phosphorus and potassium in Ghana’s interior savanna.jpg by George A. Awuni (14632778)

    Published 2024
    “…</p>Materials and methods<p>The treatments were 4 × 4 factorial combinations of P at 0, 25, 50, and 100 P<sub>2</sub>O<sub>5</sub> (kg ha<sup>−1</sup>) and K at 0, 25, 50, and 100 K<sub>2</sub>O (kg ha<sup>−1</sup>), and their combinations laid out in a randomized complete block design with four replications. …”
  3. 11703
  4. 11704

    DataSheet1_New series of 4,6-diaryl pyrimidines: facile synthesis and antiproliferative activity as dual EGFR/VEGFR-2 inhibitors.PDF by Yaser A. Mostafa (12395014)

    Published 2024
    “…Introduction<p>We developed and produced a new series of 4,6-diaryl-pyrimidines 9–29 as antiproliferative agents targeting EGFR/VEGFR-2.…”
  5. 11705

    DataSheet_1_Rituximab at lower dose for neuromyelitis optica spectrum disorder: a multicenter, open-label, self-controlled, prospective follow-up study.docx by Daidi Zhao (5179145)

    Published 2023
    “…Totally, 108 NMOSD patients were enrolled and a lower-dose RTX strategy was applied including 100 mg weekly for 3 weeks and then reinfusions every 6 months. …”
  6. 11706

    Table_1_Cost-Effectiveness of Lorlatinib as a First-Line Therapy for Untreated Advanced Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer.docx by SiNi Li (10276571)

    Published 2021
    “…Scenario analysis demonstrated that lorlatinib has 100% cost-effectiveness at a WTP threshold of 200,000/QALY compared to crizotinib treatment when the price of lorlatinib is decreased to 75% ($424.5) of its original price.…”
  7. 11707

    DataSheet1_Global burden of chronic kidney disease in adolescents and young adults, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019.docx by Ping Sun (59933)

    Published 2024
    “…However, the global age-specific death rate significantly decreased from 2.96 (2.76, 3.15) to 2.86 (2.61, 3.11), and the age-specific DALY rate remained stable. …”
  8. 11708

    Comprehensive Evaluation and Implementation of Improvement Actions in Butcher Shops by Gerardo A. Leotta (3115335)

    Published 2016
    “…A comprehensive evaluation was made and risk was quantified on a 1–100 scale as high-risk (1–40), moderate-risk (41–70) or low-risk (71–100). …”
  9. 11709

    DataSheet_1_Leveraging intelligent optimization for automated, cardiac-sparing accelerated partial breast treatment planning.xlsx by Joel A. Pogue (14597114)

    Published 2023
    “…Here we investigate the feasibility of automatically generating high quality APBI plans in the Ethos adaptive workspace with a specific emphasis on sparing the heart.…”
  10. 11710

    Table_1_Leveraging intelligent optimization for automated, cardiac-sparing accelerated partial breast treatment planning.docx by Joel A. Pogue (14597114)

    Published 2023
    “…Here we investigate the feasibility of automatically generating high quality APBI plans in the Ethos adaptive workspace with a specific emphasis on sparing the heart.…”
  11. 11711

    Table_1_Effectiveness of sofosbuvir-based treatments for patients with hepatitis C virus genotype 6 infection: a real-world study from East China.DOC by Fan-Rong Jiang (20325720)

    Published 2024
    “…In PP population, the end of treatment virological response rate was 99.48% (190/191), the SVR12 rate was 99.31% (143/144), and the SVR24 rate was 100.00% (75/75). Only one patient with genotype 6a experienced a relapse 12 weeks after the completion of treatment, but her HCV RNA was undetectable both at the end of treatment and 24 weeks after the end of treatment. …”
  12. 11712

    Table 1_Effect of acarbose and vildagliptin on plasma trimethylamine N-oxide levels in patients with type 2 diabetes mellitus: a 6-month, two-arm randomized controlled trial.docx by Xinhui Yang (12051251)

    Published 2025
    “…Intragroup analysis indicated a significant decrease in TMAO levels at 6 months compared with baseline (adjusted p<0.05). …”
  13. 11713

    Table 3_Effect of acarbose and vildagliptin on plasma trimethylamine N-oxide levels in patients with type 2 diabetes mellitus: a 6-month, two-arm randomized controlled trial.docx by Xinhui Yang (12051251)

    Published 2025
    “…Intragroup analysis indicated a significant decrease in TMAO levels at 6 months compared with baseline (adjusted p<0.05). …”
  14. 11714

    Table 2_Effect of acarbose and vildagliptin on plasma trimethylamine N-oxide levels in patients with type 2 diabetes mellitus: a 6-month, two-arm randomized controlled trial.docx by Xinhui Yang (12051251)

    Published 2025
    “…Intragroup analysis indicated a significant decrease in TMAO levels at 6 months compared with baseline (adjusted p<0.05). …”
  15. 11715

    Data Sheet 1_Global, regional, and national trends and burden of multiple sclerosis in adolescents and young adults: a data analysis from 1990 to 2021 and projections to 2040.zip by Peixi Zhao (620068)

    Published 2025
    “…</p>Methods<p>Using data from the GBD 2021 data, we conducted a secondary analysis. We assessed the prevalence, mortality, and disability-adjusted life years (DALYs) of MS across 204 countries/territories from 1990 to 2021, calculating age-standardized rates.…”
  16. 11716

    Data Sheet 2_Global, regional, and national trends and burden of multiple sclerosis in adolescents and young adults: a data analysis from 1990 to 2021 and projections to 2040.docx by Peixi Zhao (620068)

    Published 2025
    “…</p>Methods<p>Using data from the GBD 2021 data, we conducted a secondary analysis. We assessed the prevalence, mortality, and disability-adjusted life years (DALYs) of MS across 204 countries/territories from 1990 to 2021, calculating age-standardized rates.…”
  17. 11717
  18. 11718

    Supplementary Material for: A Case of Granulocyte-Colony-Stimulating Factor-Producing Non-Small Cell Lung Cancer under Steroid Treatment and with Poor Performance Status that respo... by Egusa H. (19645753)

    Published 2024
    “…She had fever and her PS was 3, and her CRP was 6.47 mg/dL due to inflammation by a G-CSF-producing tumor. Thus, we initiated the administration of dexamethasone (3.3 mg/day). …”
  19. 11719

    Table_1_Association of Yogurt and Dietary Supplements Containing Probiotic Consumption With All-Cause and Cause-Specific Mortality in US Adults: A Population-Based Cohort Study.XLS by Ping Lin (146330)

    Published 2022
    “…</p>Methods<p>We conducted an observational cohort study comprised of a nationally representative sample of adults who were enrolled in the National Health and Nutrition Examination Survey (NHANES) between 1999 and 2014. …”
  20. 11720

    Data_Sheet_1_Platelet Measurements and Type 2 Diabetes: Investigations in Two Population-Based Cohorts.docx by Benjamin A. T. Rodriguez (9107027)

    Published 2020
    “…<p>Type 2 diabetes is a major risk factor for cardiovascular disease. …”